Zhu-Ming Zhang1, Pentti M Rautaharju2, Ronald J Prineas2, Carlos J Rodriguez2, Laura Loehr2, Wayne D Rosamond2, Dalane Kitzman2, David Couper2, Elsayed Z Soliman2. 1. From Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Division of Public Health Sciences(Z.M.Z., P.M.R., R.J.P., E.Z.S.), Department of Internal Medicine, Section of Cardiology(C.J.R., D.K., E.Z.S.), and Department of Epidemiology and Prevention, Division of Public Health Sciences(C.J.R.), Wake Forest School of Medicine, Winston-Salem, NC; and Department of Epidemiology, Gillings School of Global Public Health(L.L., W.D.R.) and Gillings School of Global Public Health (D.C.), University of North Carolina at Chapel Hill. zmzhang@wakehealth.edu. 2. From Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Division of Public Health Sciences(Z.M.Z., P.M.R., R.J.P., E.Z.S.), Department of Internal Medicine, Section of Cardiology(C.J.R., D.K., E.Z.S.), and Department of Epidemiology and Prevention, Division of Public Health Sciences(C.J.R.), Wake Forest School of Medicine, Winston-Salem, NC; and Department of Epidemiology, Gillings School of Global Public Health(L.L., W.D.R.) and Gillings School of Global Public Health (D.C.), University of North Carolina at Chapel Hill.
Abstract
BACKGROUND: Race and sex differences in silent myocardial infarction (SMI) are not well established. METHODS AND RESULTS: The analysis included 9498 participants from the Atherosclerosis Risk in Communities (ARIC) study who were free of cardiovascular disease at baseline (visit 1, 1987-1989). Incident SMI was defined as ECG evidence of MI without clinically documented MI (CMI) after the baseline until ARIC visit 4 (1996-1998). Coronary heart disease and all-cause deaths were ascertained starting from ARIC visit 4 until 2010. During a median follow-up of 8.9 years, 317 participants (3.3%) developed SMI and 386 (4.1%) developed CMI. The incidence rates of both SMI and CMI were higher in men (5.08 and 7.96 per 1000-person years, respectively) than in women (2.93 and 2.25 per 1000-person years, respectively; P<0.0001 for both). Blacks had a nonsignificantly higher rate of SMI than whites (4.45 versus 3.69 per 1000-person years; P=0.217), but whites had higher rate of CMI than blacks (5.04 versus 3.24 per 1000-person years; P=0.002). SMI and CMI (compared with no MI) were associated with increased risk of coronary heart disease death (hazard ratio, 3.06 [95% confidence interval, 1.88-4.99] and 4.74 [95% confidence interval, 3.26-6.90], respectively) and all-cause mortality (hazard ratio, 1.34 [95% confidence interval, 1.09-1.65] and 1.55 [95% confidence interval, 1.30-1.85], respectively). However, SMI and CMI were associated with increased mortality among both men and women, with potentially greater increased risk among women (interaction P=0.089 and 0.051, respectively). No significant interactions by race were detected. CONCLUSIONS: SMI represents >45% of incident MIs and is associated with poor prognosis. Race and sex differences in the incidence and prognostic significance of SMI exist that may warrant considering SMI in personalized assessments of coronary heart disease risk.
BACKGROUND: Race and sex differences in silent myocardial infarction (SMI) are not well established. METHODS AND RESULTS: The analysis included 9498 participants from the Atherosclerosis Risk in Communities (ARIC) study who were free of cardiovascular disease at baseline (visit 1, 1987-1989). Incident SMI was defined as ECG evidence of MI without clinically documented MI (CMI) after the baseline until ARIC visit 4 (1996-1998). Coronary heart disease and all-cause deaths were ascertained starting from ARIC visit 4 until 2010. During a median follow-up of 8.9 years, 317 participants (3.3%) developed SMI and 386 (4.1%) developed CMI. The incidence rates of both SMI and CMI were higher in men (5.08 and 7.96 per 1000-person years, respectively) than in women (2.93 and 2.25 per 1000-person years, respectively; P<0.0001 for both). Blacks had a nonsignificantly higher rate of SMI than whites (4.45 versus 3.69 per 1000-person years; P=0.217), but whites had higher rate of CMI than blacks (5.04 versus 3.24 per 1000-person years; P=0.002). SMI and CMI (compared with no MI) were associated with increased risk of coronary heart disease death (hazard ratio, 3.06 [95% confidence interval, 1.88-4.99] and 4.74 [95% confidence interval, 3.26-6.90], respectively) and all-cause mortality (hazard ratio, 1.34 [95% confidence interval, 1.09-1.65] and 1.55 [95% confidence interval, 1.30-1.85], respectively). However, SMI and CMI were associated with increased mortality among both men and women, with potentially greater increased risk among women (interaction P=0.089 and 0.051, respectively). No significant interactions by race were detected. CONCLUSIONS: SMI represents >45% of incident MIs and is associated with poor prognosis. Race and sex differences in the incidence and prognostic significance of SMI exist that may warrant considering SMI in personalized assessments of coronary heart disease risk.
Authors: David Aguilar; Samuel Z Goldhaber; Daniel J Gans; Andrew S Levey; Jerome G Porush; Julia B Lewis; Jean-Lucien Rouleau; Tomas Berl; Edmund J Lewis; Marc A Pfeffer Journal: Am J Cardiol Date: 2004-08-01 Impact factor: 2.778
Authors: Lori L Boland; Aaron R Folsom; Paul D Sorlie; Herman A Taylor; Wayne D Rosamond; Lloyd E Chambless; Lawton S Cooper Journal: Am J Cardiol Date: 2002-11-01 Impact factor: 2.778
Authors: Waqas T Qureshi; Zhu-Ming Zhang; Patricia P Chang; Wayne D Rosamond; Dalane W Kitzman; Lynne E Wagenknecht; Elsayed Z Soliman Journal: J Am Coll Cardiol Date: 2018-01-02 Impact factor: 24.094
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: M Yldau van der Ende; Joylene E Siland; Harold Snieder; Pim van der Harst; Michiel Rienstra Journal: Clin Cardiol Date: 2017-06-12 Impact factor: 2.882
Authors: Anthony A Bavry; Islam Y Elgendy; Yedid Elbez; Ahmed N Mahmoud; Emmanuel Sorbets; Philippe Gabriel Steg; Deepak L Bhatt Journal: Clin Cardiol Date: 2017-05-18 Impact factor: 2.882
Authors: Suman L Sood; Dunlei Cheng; Margaret Ragni; Craig M Kessler; Doris Quon; Amy D Shapiro; Nigel S Key; Marilyn J Manco-Johnson; Adam Cuker; Christine Kempton; Tzu-Fei Wang; M Elaine Eyster; Philip Kuriakose; Annette von Drygalski; Joan Cox Gill; Allison Wheeler; Peter Kouides; Miguel A Escobar; Cindy Leissinger; Sarah Galdzicka; Marshall Corson; Crystal Watson; Barbara A Konkle Journal: Blood Adv Date: 2018-06-12
Authors: Richard Brandon Stacey; Janice Zgibor; Paul E Leaverton; Douglas D Schocken; Jennifer A Peregoy; Mary F Lyles; Alain G Bertoni; Gregory L Burke Journal: J Am Geriatr Soc Date: 2018-10-09 Impact factor: 5.562
Authors: Lisandro D Colantonio; Christopher M Gamboa; Joshua S Richman; Emily B Levitan; Elsayed Z Soliman; George Howard; Monika M Safford Journal: Circulation Date: 2017-07-11 Impact factor: 29.690
Authors: M Kruska; C Fastner; J F Scheitz; A Kolb; M Rutsch; T Papavassiliu; M Borggrefe; A Alonso; I Akin; K Szabo; S Baumann Journal: Herz Date: 2020-07-06 Impact factor: 1.443